V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000010 | 230000004 | 0 | 70.4 | Adjuvant (A) | 2014-08-13 | 2014-08-19 | Capecitabine + Oxaliplatin 21day | N | N | 230014902 | CAPECITABINE + OXALIPLATIN |
| 230000011 | 230000005 | 1.5 | 62 | Adjuvant (A) | 2016-03-30 | 2016-04-21 | Oxaliplatin + Modified de Gramont | 02 | N | 230015131 | CAPECITABINE + OXALIPLATIN |
| 230000012 | 230000006 | null | 49.2 | Not known (9) | 2015-05-13 | 2015-05-20 | CAPECITABINE + MITOMYCIN + RT | N | null | 230015198 | OXALIPLATIN + MDG |
| 230000013 | 230000006 | 1.7 | 81.08 | null | 2015-03-15 | 2015-03-22 | Capecitabine | 2 | N | 230015198 | CAPE + CETUXIMAB + OXALIPLATIN |
| 230000014 | 230000006 | 1.56 | 68 | Adjuvant (A) | 2018-05-30 | 2018-06-05 | Oxaliplatin + Modified de Gramont | N | Y | 230015198 | IRINOTECAN + MDG |
| 230000015 | 230001624 | 1.78 | 48.2 | Neo-adjuvant (N) | 2014-02-12 | 2014-02-20 | CAPECITABINE + OXALIPLATIN | N | null | 230015362 | CAPECITABINE + RT |
| 230000016 | 230000007 | 1.79 | 95.1 | Palliative (P) | 2016-07-14 | 2016-07-29 | R Chlorambucil | 2 | Y | 230015463 | CARBOPLATIN + ETOPOSIDE |
| 230000017 | 230000008 | 1.57 | 71 | Curative (C) | 2015-03-16 | 2015-03-30 | Capecitabine + Oxaliplatin 21day | N | Y | 230015520 | CAPECITABINE |
| 230000018 | 230000008 | 1.75 | 65.4 | Adjuvant (A) | 2014-04-26 | 2014-05-03 | CARBOPLATIN + PACLITAXEL | 2 | N | 230015520 | VANDETANIB |
| 230000019 | 230000008 | 1.42 | 60.7 | null | null | 2016-05-24 | Sorafenib | null | null | 230015520 | OXALIPLATIN + MDG |
| 230000020 | 230000008 | 1.76 | null | null | 2013-04-09 | 2013-04-23 | BCG Intravesical | N | null | 230015520 | CAPECITABINE |
| 230000021 | 230000008 | 1.9 | 91.5 | Neo-adjuvant (N) | null | 2014-07-16 | Capecitabine | N | Y | 230015520 | CAPECITABINE + OXALIPLATIN |
| 230000022 | 230000009 | 1.6 | 82 | Not known (9) | 2013-10-11 | 2013-10-15 | Sorafenib | 02 | N | 230015964 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230000023 | 230000010 | 1.52 | 58.4 | Curative (C) | 2017-07-12 | 2017-07-17 | CAP + RT | N | null | 230015977 | FLUOROURACIL |
| 230000024 | 230000011 | 1.7 | 92.8 | Palliative (P) | 2016-09-16 | 2016-10-15 | CAPECITABINE + MITOMYCIN + RT | 1 | N | 230016026 | FLUOROURACIL |
| 230000025 | 230000012 | 1.59 | 64 | Neo-adjuvant (N) | 2016-09-16 | 2016-09-16 | Capecitabine 35days + RT | 02 | null | 230016045 | CAPE + CETUXIMAB + OXALIPLATIN |
| 230000026 | 230000013 | 1.74 | 73.1 | Not known (9) | 2016-06-20 | 2016-06-25 | Capecitabine 35days + RT | 02 | N | 230016049 | CAPECITABINE + OXALIPLATIN |
| 230000027 | 230000014 | 1.6 | null | Adjuvant (A) | 2016-07-08 | 2016-07-30 | Carboplatin + Pemetrexed | null | N | 230016065 | CAPECITABINE |
| 230000028 | 230000014 | 0 | 70 | Adjuvant (A) | 2014-07-28 | 2014-07-31 | Capecitabine | N | N | 230016065 | CETUXIMAB + IRINOTECAN + MDG |
| 230000029 | 230000015 | 1.9 | 86.3 | Palliative (P) | 2014-02-25 | 2014-03-12 | Irinotecan + Modified De Gramont | 02 | N | 230016090 | OXALIPLATIN + MDG |
| 230000030 | 230000016 | 1.67 | 0 | Adjuvant (A) | 2016-07-11 | 2016-07-22 | Oxaliplatin + Modified de Gramont | N | N | 230016132 | CAPECITABINE + OXALIPLATIN |
| 230000031 | 230000017 | 1.68 | 61 | Adjuvant (A) | 2016-08-23 | 2016-08-23 | Capecitabine + Oxaliplatin 21day | N | N | 230016192 | CAPECITABINE + RT |
| 230000032 | 230000017 | 1.56 | null | Palliative (P) | 2016-12-18 | 2016-12-18 | Capecitabine + Oxaliplatin 21day | 02 | null | 230016192 | CAPECITABINE |
| 230000033 | 230000017 | 1.62 | 52 | Adjuvant (A) | 2017-06-08 | 2017-06-08 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 230016192 | OCTREOTIDE |
| 230000034 | 230001626 | 1.73 | 72 | Disease modification (D) | 2016-07-21 | 2016-07-24 | CAPECITABINE + OXALIPLATIN | 02 | N | 230016344 | CAPECITABINE + OXALIPLATIN |
| 230000035 | 230000018 | 1.7 | 107 | Palliative (P) | 2017-07-21 | 2017-08-03 | Fluorouracil + Folinic Acid Weekly | N | N | 230016560 | CAPECITABINE + IRINOTECAN |
| 230000036 | 230000018 | 1.68 | 115 | Palliative (P) | 2016-08-13 | 2016-09-09 | Carboplatin + Pemetrexed | N | N | 230016560 | OXALIPLATIN + MDG |
| 230000037 | 230000018 | null | null | Palliative (P) | 2018-05-05 | 2018-05-05 | Capecitabine + Oxaliplatin 21day | N | null | 230016560 | TRIAL |
| 230000038 | 230000019 | 1.61 | 69 | Palliative (P) | 2016-07-05 | 2016-07-07 | FEC + DOCETAXEL | 02 | N | 230016762 | FLUOROURACIL |
| 230000039 | 230000020 | 1.77 | 80.4 | Palliative (P) | 2018-01-27 | 2018-02-09 | Fluorouracil + Folinic Acid Weekly | 02 | N | 230016777 | OXALIPLATIN + MDG |
| 230000040 | 230000021 | 1.81 | 73 | Palliative (P) | 2014-02-17 | 2015-02-22 | Irinotecan + Modified De Gramont | N | N | 230016803 | OXALIPLATIN + MDG |
| 230000041 | 230000021 | 1.65 | 130.7 | null | 2014-01-14 | 2014-02-11 | Carboplatin AUC 6 - 10 | N | null | 230016803 | FLUOROURACIL |
| 230000042 | 230000022 | 1.72 | null | Curative (C) | 2017-09-09 | 2017-09-25 | Carboplatin + Etoposide iv&po | N | N | 230016815 | CAPECITABINE + OXALIPLATIN |
| 230000043 | 230000023 | 1.69 | 96.8 | Adjuvant (A) | 2014-01-28 | 2014-01-29 | Capecitabine + Oxaliplatin 21day | 02 | N | 230016834 | CAPECITABINE + OXALIPLATIN |
| 230000044 | 230000024 | null | 102.2 | Palliative (P) | 2015-06-05 | 2015-06-05 | Oxaliplatin + Modified de Gramont | null | N | 230016895 | CAPECITABINE |
| 230000045 | 230000025 | 1.67 | 75.35 | Neo-adjuvant (N) | 2014-08-07 | 2014-08-23 | Erlotinib | N | Y | 230016971 | FLUOROURACIL |
| 230000046 | 230000026 | 1.63 | 103 | Adjuvant (A) | 2014-03-28 | 2014-04-02 | Cape + Cetuximab +Irinotecan - Load | N | N | 230017151 | CAPECITABINE + OXALIPLATIN |
| 230000047 | 230000026 | -1 | 70.8 | Adjuvant (A) | 2013-05-24 | 2013-05-26 | Paclitaxel albumin (Abraxane) 21day | N | N | 230017151 | FLUOROURACIL |
| 230000048 | 230000027 | null | 88.2 | Palliative (P) | 2016-04-12 | 2016-05-04 | CAP + RT | N | N | 230017291 | OXALIPLATIN + MDG |
| 230000049 | 230000028 | 1.6 | 71.6 | Neo-adjuvant (N) | 2017-06-03 | 2017-06-23 | Hydroxycarbamide | 02 | N | 230017296 | FLUOROURACIL + MITOMYCIN |
| 230000050 | 230000029 | 1.7 | 77.9 | Neo-adjuvant (N) | 2017-10-21 | 2017-10-29 | Capecitabine + Oxaliplatin 21day | 2 | Y | 230017336 | OXALIPLATIN + MDG |
| 230000051 | 230001068 | 1.8 | 87 | Adjuvant (A) | 2014-01-07 | 2014-05-04 | Capecitabine 35days + RT | null | N | 230017358 | OXALIPLATIN + MDG |
| 230000052 | 230000030 | 1.83 | 86.7 | Adjuvant (A) | null | 2013-04-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230017412 | FLUOROURACIL + MITOMYCIN + RT |
| 230000053 | 230000031 | 1.81 | 76 | Palliative (P) | null | 2015-12-18 | CAPECITABINE + OXALIPLATIN | N | y | 230017501 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 230000054 | 230000032 | 1.64 | 75 | Palliative (P) | 2017-12-22 | 2018-02-08 | Capecitabine | N | N | 230017588 | CAPECITABINE + RT |
| 230000055 | 230001069 | 1.7 | 66 | Not known (9) | 2017-03-19 | 2017-03-25 | DOXORUBICIN | N | null | 230017631 | CAPECITABINE + OXALIPLATIN |
| 230000056 | 230001069 | 1.67 | 69.799 | null | 2015-06-23 | 2015-06-23 | Bendamustine+Rituximab (1st Course) | N | null | 230017631 | CAPECITABINE + RT |
| 230000057 | 230000033 | 1.63 | 42.2 | Neo-adjuvant (N) | 2016-05-02 | 2016-05-16 | FLUOROURACIL | N | N | 230017678 | CAPECITABINE + OXALIPLATIN |
| 230000058 | 230000034 | null | null | null | 2018-06-02 | 2018-07-02 | Oxaliplatin + Modified de Gramont | N | null | 230017679 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230000059 | 230000035 | 1.64 | 73 | Curative (C) | 2017-09-30 | 2017-10-19 | CAPECITABINE + OXALIPLATIN | N | N | 230017868 | CAPECITABINE |